Consultation record

Submissions accepted in part — page 4

Part of the submission is accepted and part is not. The secretariat response states which part is which and on what ground the remainder was declined.

Submissions

377 documents · page 4 of 13

Table 1. Submissions with this disposition, on this page.

Reference	Consultation	Respondent	Point raised
DRAFT-ADOLESCENT-S/015	Draft synthesis: incretin receptor agonists in adolescents	Dr Wolfram Tollemache	Two included studies do not meet the registered eligibility criteria
DRAFT-ADOLESCENT-S/008	Draft synthesis: incretin receptor agonists in adolescents	Hortensia Beauchamp-Ekong	The choice of effect measure is not justified and changes the appearance of the result
DRAFT-ANALYTICAL-S/007	Draft analytical review: surveys of unregulated peptide supply	Dr Frideswide Hazelrigg	Two included studies do not meet the registered eligibility criteria
DRAFT-ANALYTICAL-S/011	Draft analytical review: surveys of unregulated peptide supply	Dr Quentin Enthoven	The document is unreadable without specialist training
DRAFT-ANALYTICAL-S/009	Draft analytical review: surveys of unregulated peptide supply	Dr Thaddeus Isaksen-Balogun	Statistical heterogeneity is treated as though it measured clinical heterogeneity
DRAFT-ANALYTICAL-S/012	Draft analytical review: surveys of unregulated peptide supply	Dr Emiliana Ollerenshaw	The same concern is used to downgrade in two domains
DRAFT-ANALYTICAL-S/013	Draft analytical review: surveys of unregulated peptide supply	Dr Liesbeth Achterberg	Patient-reported outcomes are collected by the trials and not reported by the review
DRAFT-REGISTRY-STR/007	Draft structure of the document registry	Dr Séverin Oppenheimer-Ade	The front matter delays the reader from reaching the assessment
DRAFT-REGISTRY-STR/001	Draft structure of the document registry	Dr Ivo Quintanilha	The document is unreadable without specialist training
DRAFT-REGISTRY-STR/005	Draft structure of the document registry	Dr Torvald Kettlewell	References should carry a persistent identifier for every cited source
DRAFT-TOOLS-DISCLA/001	Draft terms for the Institute’s calculators	Dr Rurik Underhill-Okafor	A party criticised in an assessment should have a right of reply
DRAFT-TOOLS-DISCLA/002	Draft terms for the Institute’s calculators	Xenia Nyquist-Obiora	The secretariat answers submissions and is not itself named
DRAFT-TOOLS-DISCLA/003	Draft terms for the Institute’s calculators	Nkechi Larsson-Ekwueme	The document is unreadable without specialist training
DRAFT-ORFORGLIPRON/003	Draft monograph: orforglipron	Dr Abimbola Sotomayor-Ekwueme	Trials are described as terminated where they completed as planned
DRAFT-DANUGLIPRON-/003	Draft monograph: danuglipron	Dr Jolyon Grünbaum-Sowande	Trials are described as terminated where they completed as planned
DRAFT-METHODOLOGY-/002	Draft methodology document, version 4	Dr Quintus Kettlewell	Preprints and conference abstracts are excluded categorically
DRAFT-METHODOLOGY-/015	Draft methodology document, version 4	Dr Jolyon Grünbaum-Sowande	The document is unreadable without specialist training
DRAFT-METHODOLOGY-/017	Draft methodology document, version 4	Dr Georgiana Mountstephen	References should carry a persistent identifier for every cited source
DRAFT-METHODOLOGY-/009	Draft methodology document, version 4	Dr Vasilisa Immelmann	Point estimates are given without an interval
DRAFT-METHODOLOGY-/008	Draft methodology document, version 4	Dr Hamish Nyquist-Obiora	The conditions for upgrading observational evidence are too permissive
DRAFT-SUPPLIERS-CO/014	Draft supplier comparison table	Dr Ludmila Tollemache	A fixed section structure will force empty sections
DRAFT-SUPPLIERS-CO/003	Draft supplier comparison table	Dr Amara Vandergraaf	Point estimates are given without an interval
DRAFT-SUPPLIERS-CO/008	Draft supplier comparison table	Dr Xenia Uttridge	The document is unreadable without specialist training
DRAFT-SUPPLIERS-CO/004	Draft supplier comparison table	Dr Hyacinth Oyelaran-Steen	References should carry a persistent identifier for every cited source
DRAFT-SUPPLIERS-CO/012	Draft supplier comparison table	Dr Dmitri Nordhagen	The series scope is drawn widely enough to absorb documents that belong elsewhere
DRAFT-RETATRUTIDE-/003	Draft monograph: retatrutide	Dr Amara Quaresma	The document is unreadable without specialist training
DRAFT-RETATRUTIDE-/013	Draft monograph: retatrutide	Dr Frideswide Hazelrigg industry	The monograph should reproduce the approved labelling rather than paraphrase it
DRAFT-RETATRUTIDE-/014	Draft monograph: retatrutide	Hortensia Hollingworth	Storage and reconstitution guidance is given without stating what it rests on
DRAFT-RETATRUTIDE-/007	Draft monograph: retatrutide	Dr Jacinta Steenkamp-Ferreira	Trials are described as terminated where they completed as planned
DRAFT-MELANOCORTIN/009	Draft scoping review: melanocortin receptor agonists	Dr Séverine Oduya-Kaltenbrunner	Studies not published in English were excluded without assessment

page 4 of 13